Application 076884
- Type
- ANDA
- Sponsor
- FOUGERA PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALCLOMETASONE DIPROPIONATE | ALCLOMETASONE DIPROPIONATE | OINTMENT;TOPICAL | 0.05% | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076884-001 | ALCLOMETASONE DIPROPIONATE | ALCLOMETASONE DIPROPIONATE | 0.05% | OINTMENT / TOPICAL | AB | RS | 2005-07-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A076884-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076884-001 | ALCLOMETASONE DIPROPIONATE | 0.05% | OINTMENT / TOPICAL | AB | RS | 2005-07-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076884-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alclometasone Dipropionate | ALCLOMETASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | 3b0dccd6-dee1-49dd-8c6d-82df5c7ee36c | 2025-08-13 | Adverse reactions | Alclometasone Dipropionate ALCLOMETASONE DIPROPIONATE |
| Alclometasone dipropionate | ALCLOMETASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | 3e688309-880a-4890-bf00-90afd19084f6 | 2025-07-29 | Adverse reactions | Alclometasone dipropionate ALCLOMETASONE DIPROPIONATE |
| Alclometasone Dipropionate | ALCLOMETASONE DIPROPIONATE | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 6aacce3f-aa2f-4f2c-a5bd-8cff157a3dab | 2025-07-09 | Adverse reactions | Alclometasone Dipropionate ALCLOMETASONE DIPROPIONATE |
| Alclometasone Dipropionate | ALCLOMETASONE DIPROPIONATE | Glenmark Pharmaceuticals Inc., USA | 63e635e0-65d8-4b30-9f2a-ab16deba90bd | 2021-04-05 | Adverse reactions | Alclometasone Dipropionate ALCLOMETASONE DIPROPIONATE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0168-0264 | Alclometasone Dipropionate | alclometasone dipropionate | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 0168-0264 | Alclometasone Dipropionate | alclometasone dipropionate | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 0168-0264 | Alclometasone Dipropionate | alclometasone dipropionate | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | Current |